Skip to main content

Bladder Exstrophy-Epispadias Complex

The bladder exstrophy-epispadias complex (BEEC) is a rare congenital spectrum of genitourinary malformations (prevalence ≈ 1 in 10,000 births) that demands lifelong multidisciplinary care. As childhood survivors reach adulthood in growing numbers, adult and transitional urology now carries an increasingly central role in their management.[1][2]

For the adult reconstructive urologist, BEEC is a problem of continence reconstruction that frequently outlasts the native bladder, of bowel incorporated into the urinary tract with its lifelong metabolic and oncologic consequences, of genital and abdominal-wall reconstruction, and of fertility, pregnancy, and psychosocial burden. Because the European consensus holds that these patients require lifelong follow-up at specialist centers, this article sits within Transitional Urology rather than under prolapse or incontinence.[2]

Spectrum and Overview​

BEEC spans a range of severity: isolated epispadias (mildest), classic bladder exstrophy (CBE), and cloacal exstrophy / OEIS complex (most severe). The defect involves the urinary tract, abdominal wall, musculoskeletal pelvis, pelvic floor, and genitalia — and sometimes the spine and anus.[1][3] Management is primarily surgical, beginning in the neonatal period, with the staged goals of abdominal-wall closure, urinary continence, renal preservation, and genital reconstruction.[1]

Urinary Continence and Lower Urinary Tract Function in Adults​

Continence is the dominant issue in transitional care, and most patients require multiple procedures over a lifetime.

  • Few void normally per urethra. Only ~25% of classic bladder exstrophy patients are expected to void per urethra without catheterization or diversion. A French long-term cohort (median follow-up 22 years) found only 21.4% voided spontaneously per urethra while 76.2% performed clean intermittent self-catheterization (CISC).[4][5]
  • The need for augmentation or diversion rises with age — roughly 50% by age 10 and ~70% by age 18 in a 36-year multi-institutional cohort; among adults without diversion, 85.5% performed CIC.[6]
  • LUTS are common but under-recognized — moderate-to-severe symptoms in 80% of males and 67% of females, many apparent only on detailed validated questionnaires.[7]
  • Continence depends heavily on the procedure. After bladder neck closure with a continent catheterizable stoma, continence reaches 93%, versus 64% after isolated bladder neck reconstruction.[4]

Continence Surgery — Approach and Outcomes​

The approach is a stepwise escalation:

ProcedureContinenceNotes
Bladder neck reconstruction (BNR) — modified Young-Dees-Leadbetter≈ 64% (≥3-hour dry interval)Most common technique; failure usually reflects inadequate capacity / compliance. No patient needing redo BNR voided per urethra without CIC[4][8]
BNR + augmentation cystoplasty ± continent catheterizable stomaHigher than isolated BNRAdded when capacity / compliance is insufficient; redo BNR is most effective combined with augmentation[5][6]
Bladder neck closure (BNC) + continent catheterizable stoma93% (95% CI 87–97%)Most reliable continence option; reserved for BNR failure or non-candidates for volitional voiding[4]
Combined BNR + continent stoma71% (preliminary)Hybrid for borderline BNR candidates who strongly desire volitional voiding; 60% of failures later needed bladder-neck transection[9]
Endoscopic bulking (dextranomer / hyaluronic acid)5-yr failure-free 70% (male epispadias), 45% (female)Better after prior BNR; a lower-morbidity adjunct[10]
Artificial urinary sphincter (AS792)91% (historical)Largely supplanted by reconstructive techniques[11]

Continent Urinary Diversion — Options and Long-Term Complications​

When the native bladder cannot be preserved or is inadequate, continent diversion is performed. These reservoirs commit the patient to lifelong surveillance.

  • Continent catheterizable pouches (Penn, Indiana, Mainz) — in untreated adults, 72% opted for a continent pouch with 100% continence at mean 6.5 years; the Indiana pouch shows excellent durability (mean revision-free survival ≈ 198 months / 16.5 years).[12][13]
  • Continent anal diversion — a 45-year experience reported 97% daytime continence, but with secondary rectal-reservoir malignancies, prophylactic alkaline substitution in 41%, and adverse sexual-function impact.[14]
  • Ileal conduit — the simplest option for patients with limited healthcare access, low motivation for self-catheterization, or significant comorbidity; malignancy can still arise in the conduit decades later.[12][15]
  • Stomal stenosis is the most common long-term stomal complication (25% at median 1.9 years). Monofilament suture for umbilicoplasty significantly reduces it (p = 0.009); scar contractures respond to stomal incision, keloids to excision and local tissue rearrangement.[16]
  • Bladder / pouch calculi form in 26% of continent diversions — co-leading long-term complication alongside stomal stenosis.[17]
  • Continent catheterizable channels themselves are not permanent: roughly half require ≥1 surgical revision over 12+ years.[9]

Augmentation Cystoplasty — Metabolic and Renal Monitoring​

Any bowel segment incorporated into the urinary tract obliges lifelong metabolic surveillance:[18]

  • Hyperchloremic metabolic acidosis — the most common metabolic complication, particularly with ileal or colonic segments; prophylactic alkalinization is often required.
  • Vitamin B12 deficiency — risk rises when >60 cm of terminal ileum is used; check annually.
  • Bone demineralization — chronic acidosis drives bone loss; consider DEXA.
  • Renal function — in a cross-sectional study, 74% of BEEC patients had at least one sign of kidney injury (elevated BP, reduced eGFR, or proteinuria); recurrent UTI/bacteriuria in 44% and nephrolithiasis in 29%.[19]
  • EAU/ESPU monitoring — physical exam, renal ultrasound, blood-gas (pH and base excess), renal function, and vitamin B12 (if ileum used).[18]

See also the broader augmentation surveillance discussion on the transitional-urology hub.

Malignancy Risk and Surveillance​

Adults with BEEC carry a substantially elevated bladder-malignancy risk — estimated at ~694-fold over the age-matched population by age 40.[20][21]

  • Adenocarcinoma is the most common histology, though squamous cell and urothelial carcinoma also occur.[20][22]
  • Risk is highest with ureterosigmoidostomy or other diversions mixing urine and feces (38% neoplasia), but even "low-risk" patients without such exposure carry a 3.3% rate.[20]
  • Persistent histological changes (cystitis glandularis, intestinal metaplasia, polyps) are found in up to 62% of exstrophic bladders after closure and may be premalignant.[23]
  • Augmentation itself does not clearly add cancer risk beyond the underlying congenital baseline, but immunosuppression (e.g., post-transplant) is an independent risk factor.[24]
  • Lifelong surveillance with cystoscopy and urine cytology is recommended — some authors begin before age 30 — plus annual colonoscopy for ureterosigmoidostomy.[20]

Abdominal Wall Reconstruction​

Closing the anterior abdominal-wall defect in adults is a substantial challenge:

  • Osteotomy is generally not required in adults — multiple series achieve closure without pelvic osteotomy using the vesical-plate muscular coat and/or multilayered flap reconstruction.[25][26]
  • Multilayered reconstruction with superficial fascial and myofascial flaps (rectus anterior sheath, external oblique aponeurosis) gave reliable closure with no recurrent dehiscence in a 12-patient series.[26]
  • Primary abdominal-wall closure was achieved in 87% of untreated adults in one series.[12]

Genital Reconstruction in Males​

Penile inadequacy is a major adult concern:

  • Penoplasty (corporeal mobilization, chordee correction, dermal grafting) — required in most; 92% esthetic satisfaction in one series of 65, though 29% needed revision.[27]
  • Substitution phalloplasty — for severe inadequacy when local tissue is insufficient. The radial forearm free flap is the dominant technique (89% of cases in a systematic review), overall complication rate ~15%; a penile prosthesis was implanted in 68%, with a 25% prosthesis complication rate (mainly erosion).[28]
  • A 6-year institutional experience (11 phalloplasties; 8 CBE, 3 cloacal exstrophy) reported 100% flap survival, with inflatable penile prostheses placed in five; one fatal pulmonary embolism occurred in the pedicled anterolateral-thigh-flap group.[29]

Sexual Function and Fertility​

  • Sexual function scores (erectile and general) are often comparable to controls on validated questionnaires, yet more BEEC patients have not become sexually active (35% vs 11%) and fewer have children (22% vs 45%).[30][31]
  • Male fertility is frequently impaired — oligoasthenoteratozoospermia in ~71%, weak / dribbling ejaculation common, and ~50% of men who father children require assisted reproductive technology. Early sperm banking should be discussed.[32][33]
  • Female fertility is better preserved (up to 100% in one series), though obstetric management must account for pelvic anatomy and prior surgery.[34]
  • Genital reconstruction is frequently needed to optimize sexual outcomes — 96% of men and 25% of women in one series required such procedures.[34]

Pregnancy and Obstetric Management​

Pregnancy in women with BEEC is high-risk and requires multidisciplinary planning:

  • Fertility is impaired — only 50% of women attempting conception succeeded (19/38) in one series, though others report higher rates.[35][34]
  • The miscarriage rate is high (~35%), with stillbirth / neonatal death in ~7%.[35]
  • Cesarean delivery is recommended in most cases — particularly after continent diversion — to protect reconstructed anatomy, though vaginal delivery has been reported in select cases.[35][36][37]
  • Pregnancy complications include recurrent UTI / pyelonephritis (~33%), upper-tract dilation requiring stenting / nephrostomy (~11%), and uterine prolapse.[35][38]
  • Delivery should occur at a tertiary center with urology coverage, with incision type and awareness of reconstructed reservoirs planned with the urological team in advance.[37][38]

Psychosocial and Quality of Life​

  • Generic QoL (SF-36 / RAND-36) is often comparable to the general population — though this may reflect adaptation rather than absence of burden.[31][39][40]
  • Mental-health concerns affect ~20%; depressive symptoms, anxiety, and low self-esteem around sexual relationships are common. Dissatisfaction with genital appearance and urinary incontinence are the strongest predictors of reduced QoL.[39][41][42]
  • Caregiver burden is significant (mean Zarit score 36.4), underscoring family-centered support.[41]
  • Multidisciplinary psychosocial support — behavioral health, peer support, educational consultation, and formal transition planning — is considered essential.[43]

Management of Previously Untreated Adults​

In resource-limited settings, some patients present with untreated BEEC in adulthood:

  • Continent catheterizable pouch (e.g., Penn pouch) — preferred by most patients, with excellent continence.[12]
  • Cystectomy with ileal conduit — simpler, for patients with limited healthcare access or low motivation for self-catheterization.[12][15]
  • Bladder preservation with ileocystoplasty and bladder-neck reconstruction — feasible if random biopsies show no significant dysplasia, with mandatory lifelong cancer surveillance.[44]

Lifelong Surveillance​

DomainFrequencyMethod
Renal function + upper-tract imagingAnnuallySerum creatinine / eGFR, renal ultrasound[18][19]
Metabolic panel (if bowel incorporated)Every 6–12 monthsBlood gas, electrolytes, vitamin B12 (if ileum used)[18]
Malignancy surveillancePer riskCystoscopy + cytology (augmented / diverted); annual colonoscopy for ureterosigmoidostomy[20]
Stomal assessmentEach visitInspect stoma, troubleshoot catheterization[16]
Sexual / reproductive healthPeriodicallyCounseling; early sperm banking for males; semen analysis if fertility desired[32][33]
Obstetric planningChildbearing agePre-pregnancy multidisciplinary planning; tertiary-center delivery[37]
Psychosocial / mental healthPeriodicallyScreening + validated QoL instruments[40][43]

Key Principles​

  • Continence usually outlasts the native bladder. Only ~21–25% void per urethra long-term; most end up on CIC, and ~70% need augmentation or diversion by adulthood.[4][5][6]
  • Bladder neck closure + continent catheterizable stoma is the most reliable continence construct (93%); isolated BNR achieves ~64%.[4]
  • Bowel in the urinary tract = lifelong metabolic + oncologic surveillance — acidosis, B12, stones, and a ~694-fold malignancy risk by age 40.[18][20]
  • Adult abdominal-wall closure rarely needs osteotomy — multilayered flap reconstruction is reliable.[25][26]
  • Discuss fertility early — male fertility is often impaired (ART in ~50% of fathers; offer sperm banking); female fertility is better preserved but pregnancy is high-risk and usually delivered by cesarean at a tertiary center.[32][35][37]
  • Genital appearance and incontinence drive QoL — address them proactively alongside mental-health screening and caregiver support.[41][43]

See Also​

References​

1. Ebert AK, Reutter H, Ludwig M, Rösch WH. "The Exstrophy-Epispadias Complex." Orphanet J Rare Dis. 2009;4:23. doi:10.1186/1750-1172-4-23

2. Wood D, Baird A, Carmignani L, et al. "Lifelong Congenital Urology: The Challenges for Patients and Surgeons." Eur Urol. 2019;75(6):1001-1007. doi:10.1016/j.eururo.2019.03.019

3. Lee T, Borer J. "Exstrophy-Epispadias Complex." Urol Clin North Am. 2023;50(3):403-414. doi:10.1016/j.ucl.2023.04.004

4. Maruf M, Manyevitch R, Michaud J, et al. "Urinary Continence Outcomes in Classic Bladder Exstrophy: A Long-Term Perspective." J Urol. 2020;203(1):200-205. doi:10.1097/JU.0000000000000505

5. Abdellaoui S, Cazzorla F, Morel-Journel N, et al. "Long-Term Urinary Outcomes in Classic Bladder Exstrophy: Results of an Extensive Follow-Up." BJU Int. 2025;135(6):1018-1024. doi:10.1111/bju.16680

6. Szymanski KM, Fuchs M, McLeod D, et al. "Probability of Bladder Augmentation, Diversion and Clean Intermittent Catheterization in Classic Bladder Exstrophy: A 36-Year, Multi-Institutional, Retrospective Cohort Study." J Urol. 2019;202(6):1256-1262. doi:10.1097/JU.0000000000000552

7. Taskinen S, Suominen JS. "Lower Urinary Tract Symptoms (LUTS) in Patients in Adulthood With Bladder Exstrophy and Epispadias." BJU Int. 2013;111(7):1124-1129. doi:10.1111/j.1464-410X.2012.11756.x

8. Burki T, Hamid R, Duffy P, et al. "Long-Term Followup of Patients After Redo Bladder Neck Reconstruction for Bladder Exstrophy Complex." J Urol. 2006;176(3):1138-1141. doi:10.1016/j.juro.2006.04.055

9. Polm PD, Christiaans CHH, Dik P, Wyndaele MIA, de Kort LMO. "Continent Catheterizable Urinary Channels: Lessons for Lifelong Urological Care From a Comparative Analysis of Very Long-Term Complications and Revision-Free Survival of Three Different Types." Neurourol Urodyn. 2024;43(5):1083-1089. doi:10.1002/nau.25350

10. Fiorenza V, Hukkinen M, Alova I, et al. "Dextranomer Endoscopic Injections for the Treatment of Urinary Incontinence in Bladder Exstrophy-Epispadias Complex." J Urol. 2023;209(3):591-599. doi:10.1097/JU.0000000000003086

11. Light JK, Scott FB. "Treatment of the Epispadias-Exstrophy Complex With the AS792 Artificial Urinary Sphincter." J Urol. 1983;129(4):738-740. doi:10.1016/s0022-5347(17)52336-8

12. Kiran PS, Panaiyadiyan S, Singh P, et al. "Management of Untreated Classical Bladder Exstrophy in Adults: A Single-Institutional Experience." Urology. 2020;146:293-298. doi:10.1016/j.urology.2020.09.009

13. Polm PD, Wyndaele MIA, de Kort LMO. "Very Long-Term Follow-Up of Indiana Pouches Proves Durability." Neurourol Urodyn. 2024;43(5):1090-1096. doi:10.1002/nau.25344

14. Rubenwolf PC, Hampel C, Roos F, et al. "Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience." Urology. 2017;100:249-254. doi:10.1016/j.urology.2016.11.026

15. Venkatramani V, Chandrasingh J, Devasia A, Kekre NS. "Exstrophy-Epispadias Complex Presenting in Adulthood: A Single-Center Review of Presentation, Management, and Outcomes." Urology. 2014;84(5):1243-1247. doi:10.1016/j.urology.2014.06.063

16. Harris TGW, Haffar A, Crigger CB, et al. "Stomal Stenosis After Continent Urinary Diversion in Bladder Exstrophy: Risk Factors and Management." Urology. 2024;191:110-118. doi:10.1016/j.urology.2024.07.003

17. Surer I, Ferrer FA, Baker LA, Gearhart JP. "Continent Urinary Diversion and the Exstrophy-Epispadias Complex." J Urol. 2003;169(3):1102-1105. doi:10.1097/01.ju.0000044921.19074.d0

18. Stein R, Bogaert G, Dogan HS, et al. "EAU/ESPU Guidelines on the Management of Neurogenic Bladder in Children and Adolescent Part II: Operative Management." Neurourol Urodyn. 2020;39(2):498-506. doi:10.1002/nau.24248

19. Cleper R, Blumenthal D, Beniamini Y, et al. "Exstrophy-Epispadias Complex: Are the Kidneys and Kidney Function Spared?" Pediatr Nephrol. 2023;38(8):2711-2717. doi:10.1007/s00467-023-05889-y

20. Smeulders N, Woodhouse CR. "Neoplasia in Adult Exstrophy Patients." BJU Int. 2001;87(7):623-628. doi:10.1046/j.1464-410x.2001.02136.x

21. Woodhouse CR, North AC, Gearhart JP. "Standing the Test of Time: Long-Term Outcome of Reconstruction of the Exstrophy Bladder." World J Urol. 2006;24(3):244-249. doi:10.1007/s00345-006-0053-7

22. Rieder JM, Parsons JK, Gearhart JP, Schoenberg M. "Primary Squamous Cell Carcinoma in Unreconstructed Exstrophic Bladder." Urology. 2006;67(1):199. doi:10.1016/j.urology.2005.07.008

23. Rubenwolf PC, Eder F, Ebert AK, et al. "Persistent Histological Changes in the Exstrophic Bladder After Primary Closure — a Cause for Concern?" J Urol. 2013;189(2):671-677. doi:10.1016/j.juro.2012.08.210

24. Higuchi TT, Granberg CF, Fox JA, Husmann DA. "Augmentation Cystoplasty and Risk of Neoplasia: Fact, Fiction and Controversy." J Urol. 2010;184(6):2492-2496. doi:10.1016/j.juro.2010.08.038

25. Mansour AM, Sarhan OM, Helmy TE, et al. "Management of Bladder Exstrophy Epispadias Complex in Adults: Is Abdominal Closure Possible Without Osteotomy?" World J Urol. 2010;28(2):199-204. doi:10.1007/s00345-009-0436-7

26. Azhati B, Dilixiati D, Reheman A, Li W, Yu Y. "An Analysis of the Efficacy of Multilayered Repair and Reconstruction Using Combined Tissue Pedicle Flaps for Abdominal Wall Defects in Adult Bladder Exstrophy Patients." Ann Plast Surg. 2024;92(4):437-441. doi:10.1097/SAP.0000000000003844

27. VanderBrink BA, Stock JA, Hanna MK. "Esthetic Outcomes of Genitoplasty in Males Born With Bladder Exstrophy and Epispadias." J Urol. 2007;178(4 Pt 2):1606-1610. doi:10.1016/j.juro.2007.03.192

28. Berrettini A, Sampogna G, Gnech M, et al. "Substitution Phalloplasty in Patients With Bladder Exstrophy-Epispadias Complex: A Systematic Review of Techniques, Complications and Outcomes." J Sex Med. 2021;18(2):400-409. doi:10.1016/j.jsxm.2020.10.007

29. Harris TGW, Manyevitch R, Wu WJ, et al. "Pedicled Anterolateral Thigh and Radial Forearm Free Flap Phalloplasty for Penile Reconstruction in Patients With Bladder Exstrophy." J Urol. 2021;205(3):880-887. doi:10.1097/JU.0000000000001404

30. Suominen JS, Santtila P, Taskinen S. "Sexual Function in Patients Operated on for Bladder Exstrophy and Epispadias." J Urol. 2015;194(1):195-199. doi:10.1016/j.juro.2015.01.098

31. Zhu X, Klijn AJ, de Kort LMO. "Urological, Sexual, and Quality of Life Evaluation of Adult Patients With Exstrophy-Epispadias Complex: Long-Term Results From a Dutch Cohort." Urology. 2020;136:272-277. doi:10.1016/j.urology.2019.10.011

32. Rubenwolf P, Thomas C, Thüroff JW, Stein R. "Sexual Function, Social Integration and Paternity of Males With Classic Bladder Exstrophy Following Urinary Diversion." J Urol. 2016;195(2):465-470. doi:10.1016/j.juro.2015.08.076

33. Reynaud N, Courtois F, Mouriquand P, et al. "Male Sexuality, Fertility, and Urinary Continence in Bladder Exstrophy-Epispadias Complex." J Sex Med. 2018;15(3):314-323. doi:10.1016/j.jsxm.2018.01.004

34. Sinatti C, Waterschoot M, Roth J, et al. "Long-Term Sexual Outcomes in Patients With Exstrophy-Epispadias Complex." Int J Impot Res. 2021;33(2):164-169. doi:10.1038/s41443-020-0248-2

35. Deans R, Banks F, Liao LM, et al. "Reproductive Outcomes in Women With Classic Bladder Exstrophy: An Observational Cross-Sectional Study." Am J Obstet Gynecol. 2012;206(6):496.e1-6. doi:10.1016/j.ajog.2012.03.016

36. Lachica R, Chan Y, Uquillas KR, Lee RH. "Vaginal Delivery After Dührssen Incisions in a Patient With Bladder Exstrophy and Uterine Prolapse." Obstet Gynecol. 2017;129(4):689-692. doi:10.1097/AOG.0000000000001938

37. Hosiani A, Smet ME, Nayyar R. "A Road Map for the Management of a Pregnancy Complicated by Maternal Bladder Exstrophy." BMC Pregnancy Childbirth. 2024;24(1):195. doi:10.1186/s12884-024-06316-2

38. Bey E, Perrouin-Verbe B, Reiss B, et al. "Outcomes of Pregnancy and Delivery in Women With Continent Lower Urinary Tract Reconstruction: Systematic Review of the Literature." Int Urogynecol J. 2021;32(7):1707-1717. doi:10.1007/s00192-021-04856-1

39. Taskinen S, Suominen JS, Mattila AK. "Health-Related Quality of Life and Mental Health in Adolescents and Adults Operated for Bladder Exstrophy and Epispadias." Urology. 2015;85(6):1515-1519. doi:10.1016/j.urology.2015.02.020

40. Dellenmark-Blom M, Sjöström S, Abrahamsson K, Holmdahl G. "Health-Related Quality of Life Among Children, Adolescents, and Adults With Bladder Exstrophy-Epispadias Complex: A Systematic Review of the Literature and Recommendations for Future Research." Qual Life Res. 2019;28(6):1389-1412. doi:10.1007/s11136-019-02119-7

41. Bakır AC, Emül HM, Eliçevik M, et al. "Psychological and Sexual Outcomes in Patients With Bladder Exstrophy and Their Caregivers." J Pediatr Surg. 2026;61(3):162832. doi:10.1016/j.jpedsurg.2025.162832

42. Traceviciute J, Zwink N, Jenetzky E, et al. "Sexual Function and Quality of Life in Adult Male Individuals With Exstrophy-Epispadias Complex — a Survey of the German CURE-Network." Urology. 2018;112:215-221. doi:10.1016/j.urology.2017.08.063

43. Haddad E, Hayes LC, Price D, et al. "Ensuring Our Exstrophy-Epispadias Complex Patients and Families Thrive." Pediatr Nephrol. 2024;39(2):371-382. doi:10.1007/s00467-023-06049-y

44. Pathak HR, Mahajan R, Ali NI, Kaul S, Andankar MG. "Bladder Preservation in Adult Classic Exstrophy: Early Results of Four Patients." Urology. 2001;57(5):906-910. doi:10.1016/s0090-4295(01)00959-1